United States Abbott Laboratories (ABT): Financial Highlights
United States US: ABT: Account Payables
US: ABT: Account Payables data was reported at 2,476,000.000 USD th in Mar 2018. This records an increase from the previous number of 2,402,000.000 USD th for Dec 2017. US: ABT: Account Payables data is updated quarterly, averaging 1,211,654.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 2,476,000.000 USD th in Mar 2018 and a record low of 887,802.000 USD th in Sep 2002. US: ABT: Account Payables data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 2,476,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Account Payables from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Account Receivables
US: ABT: Account Receivables data was reported at 5,356,000.000 USD th in Mar 2018. This records an increase from the previous number of 5,249,000.000 USD th for Dec 2017. US: ABT: Account Receivables data is updated quarterly, averaging 3,602,000.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 7,683,920.000 USD th in Dec 2011 and a record low of 1,941,480.000 USD th in Mar 2000. US: ABT: Account Receivables data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 5,356,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Account Receivables from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Cash Flow fm Financing Activities
US: ABT: Cash Flow fm Financing Activities data was reported at -6,455,000.000 USD th in Mar 2018. This records a decrease from the previous number of -5,281,000.000 USD th for Dec 2017. US: ABT: Cash Flow fm Financing Activities data is updated quarterly, averaging -1,154,895.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 11,147,000.000 USD th in Dec 2016 and a record low of -6,696,000.000 USD th in Dec 2013. US: ABT: Cash Flow fm Financing Activities data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| -6,455,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Cash Flow fm Financing Activities from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Cash Flow fm Investing Activities
US: ABT: Cash Flow fm Investing Activities data was reported at -238,000.000 USD th in Mar 2018. This records an increase from the previous number of -9,618,000.000 USD th for Dec 2017. US: ABT: Cash Flow fm Investing Activities data is updated quarterly, averaging -1,564,049.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 406,000.000 USD th in Dec 2015 and a record low of -12,188,315.000 USD th in Dec 2010. US: ABT: Cash Flow fm Investing Activities data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| -238,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Cash Flow fm Investing Activities from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Cash Flow fm Operating Activities
US: ABT: Cash Flow fm Operating Activities data was reported at 1,108,000.000 USD th in Mar 2018. This records a decrease from the previous number of 5,570,000.000 USD th for Dec 2017. US: ABT: Cash Flow fm Operating Activities data is updated quarterly, averaging 2,637,600.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 9,314,000.000 USD th in Dec 2012 and a record low of -93,000.000 USD th in Mar 2016. US: ABT: Cash Flow fm Operating Activities data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 1,108,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Cash Flow fm Operating Activities from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Cash and Cash Equivalents
US: ABT: Cash and Cash Equivalents data was reported at 3,857,000.000 USD th in Mar 2018. This records a decrease from the previous number of 9,407,000.000 USD th for Dec 2017. US: ABT: Cash and Cash Equivalents data is updated quarterly, averaging 2,775,249.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 18,620,000.000 USD th in Dec 2016 and a record low of 482,137.000 USD th in Jun 2002. US: ABT: Cash and Cash Equivalents data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 3,857,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Cash and Cash Equivalents from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Changes in Net Cash
US: ABT: Changes in Net Cash data was reported at -5,550,000.000 USD th in Mar 2018. This records an increase from the previous number of -9,213,000.000 USD th for Dec 2017. US: ABT: Changes in Net Cash data is updated quarterly, averaging 133,430.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 13,619,000.000 USD th in Dec 2016 and a record low of -9,914,000.000 USD th in Mar 2017. US: ABT: Changes in Net Cash data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| -5,550,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Changes in Net Cash from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Cost of Sales
US: ABT: Cost of Sales data was reported at 6,349,000.000 USD th in Jun 2018. This records an increase from the previous number of 3,067,000.000 USD th for Mar 2018. US: ABT: Cost of Sales data is updated quarterly, averaging 6,080,772.000 USD th from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 14,665,192.000 USD th in Dec 2010 and a record low of 1,496,447.000 USD th in Mar 2000. US: ABT: Cost of Sales data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 6,349,000.00 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |
View United States's United States US: ABT: Cost of Sales from Dec 1999 to Jun 2018 in the chart:
United States US: ABT: Current Assets
US: ABT: Current Assets data was reported at 14,964,000.000 USD th in Mar 2018. This records a decrease from the previous number of 20,147,000.000 USD th for Dec 2017. US: ABT: Current Assets data is updated quarterly, averaging 14,098,866.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 31,323,000.000 USD th in Dec 2012 and a record low of 6,419,754.000 USD th in Dec 1999. US: ABT: Current Assets data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 14,964,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Current Assets from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Current Liabilities
US: ABT: Current Liabilities data was reported at 9,010,000.000 USD th in Mar 2018. This records an increase from the previous number of 8,912,000.000 USD th for Dec 2017. US: ABT: Current Liabilities data is updated quarterly, averaging 9,056,639.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 17,262,434.000 USD th in Dec 2010 and a record low of 4,188,266.000 USD th in Jun 2000. US: ABT: Current Liabilities data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 9,010,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Current Liabilities from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Dividend per Share
US: ABT: Dividend per Share data was reported at 0.280 USD in Mar 2018. This records a decrease from the previous number of 1.075 USD for Dec 2017. US: ABT: Dividend per Share data is updated quarterly, averaging 0.670 USD from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 1.920 USD in Dec 2011 and a record low of 0.140 USD in Mar 2013. US: ABT: Dividend per Share data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 0.28 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Dividend per Share from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Earning per Share
US: ABT: Earning per Share data was reported at 0.640 USD in Jun 2018. This records an increase from the previous number of 0.240 USD for Mar 2018. US: ABT: Earning per Share data is updated quarterly, averaging 1.100 USD from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 3.760 USD in Dec 2012 and a record low of -0.140 USD in Mar 2001. US: ABT: Earning per Share data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 0.64 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |
View United States's United States US: ABT: Earning per Share from Dec 1999 to Jun 2018 in the chart:
United States US: ABT: Goodwill
US: ABT: Goodwill data was reported at 24,227,000.000 USD th in Mar 2018. This records an increase from the previous number of 24,020,000.000 USD th for Dec 2017. US: ABT: Goodwill data is updated quarterly, averaging 9,752,000.000 USD th from Dec 2000 (Median) to Mar 2018, with 67 observations. The data reached an all-time high of 24,227,000.000 USD th in Mar 2018 and a record low of 663,698.000 USD th in Dec 2000. US: ABT: Goodwill data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 24,227,000.00 Mar 2018 | quarterly | Dec 2000 - Mar 2018 |
View United States's United States US: ABT: Goodwill from Dec 2000 to Mar 2018 in the chart:
United States US: ABT: Gross Profit
US: ABT: Gross Profit data was reported at 8,808,000.000 USD th in Jun 2018. This records an increase from the previous number of 4,323,000.000 USD th for Mar 2018. US: ABT: Gross Profit data is updated quarterly, averaging 7,200,442.000 USD th from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 20,501,529.000 USD th in Dec 2010 and a record low of 1,856,731.000 USD th in Mar 2000. US: ABT: Gross Profit data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 8,808,000.00 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |
View United States's United States US: ABT: Gross Profit from Dec 1999 to Jun 2018 in the chart:
United States US: ABT: Intangible Asset
US: ABT: Intangible Asset data was reported at 45,170,000.000 USD th in Mar 2018. This records a decrease from the previous number of 45,493,000.000 USD th for Dec 2017. US: ABT: Intangible Asset data is updated quarterly, averaging 15,234,432.000 USD th from Dec 1999 (Median) to Mar 2018, with 71 observations. The data reached an all-time high of 45,493,000.000 USD th in Dec 2017 and a record low of 1,555,260.000 USD th in Dec 2000. US: ABT: Intangible Asset data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 45,170,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Intangible Asset from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Inventory
US: ABT: Inventory data was reported at 3,826,000.000 USD th in Mar 2018. This records an increase from the previous number of 3,601,000.000 USD th for Dec 2017. US: ABT: Inventory data is updated quarterly, averaging 2,730,089.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 3,995,000.000 USD th in Mar 2017 and a record low of 1,495,444.000 USD th in Dec 1999. US: ABT: Inventory data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 3,826,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Inventory from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Long Term Debt
US: ABT: Long Term Debt data was reported at 21,154,000.000 USD th in Mar 2018. This records a decrease from the previous number of 27,210,000.000 USD th for Dec 2017. US: ABT: Long Term Debt data is updated quarterly, averaging 5,942,000.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 27,210,000.000 USD th in Dec 2017 and a record low of 1,076,316.000 USD th in Sep 2000. US: ABT: Long Term Debt data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 21,154,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Long Term Debt from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Long Term Investments
US: ABT: Long Term Investments data was reported at 913,000.000 USD th in Mar 2018. This records an increase from the previous number of 883,000.000 USD th for Dec 2017. US: ABT: Long Term Investments data is updated quarterly, averaging 524,735.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 4,041,000.000 USD th in Dec 2015 and a record low of 118,484.000 USD th in Mar 2005. US: ABT: Long Term Investments data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 913,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Long Term Investments from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Long Term Liabilities
US: ABT: Long Term Liabilities data was reported at 30,297,000.000 USD th in Mar 2018. This records a decrease from the previous number of 36,240,000.000 USD th for Dec 2017. US: ABT: Long Term Liabilities data is updated quarterly, averaging 9,990,821.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 36,240,000.000 USD th in Dec 2017 and a record low of 2,382,395.000 USD th in Sep 2000. US: ABT: Long Term Liabilities data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 30,297,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Long Term Liabilities from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Minority Interest
US: ABT: Minority Interest data was reported at 202,000.000 USD th in Mar 2018. This records an increase from the previous number of 201,000.000 USD th for Dec 2017. US: ABT: Minority Interest data is updated quarterly, averaging 95,544.500 USD th from Dec 2007 (Median) to Mar 2018, with 38 observations. The data reached an all-time high of 202,000.000 USD th in Mar 2018 and a record low of 39,695.000 USD th in Sep 2009. US: ABT: Minority Interest data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 202,000.00 Mar 2018 | quarterly | Dec 2007 - Mar 2018 |
View United States's United States US: ABT: Minority Interest from Dec 2007 to Mar 2018 in the chart:
United States US: ABT: Net Cash/ (Debt), Period Begin
US: ABT: Net Cash/ (Debt), Period Begin data was reported at 9,407,000.000 USD th in Mar 2018. This records a decrease from the previous number of 18,620,000.000 USD th for Dec 2017. US: ABT: Net Cash/ (Debt), Period Begin data is updated quarterly, averaging 3,184,343.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 18,620,000.000 USD th in Dec 2017 and a record low of 315,238.000 USD th in Dec 1999. US: ABT: Net Cash/ (Debt), Period Begin data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 9,407,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Net Cash/ (Debt), Period Begin from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Net Cash/ (Debt), Period End
US: ABT: Net Cash/ (Debt), Period End data was reported at 3,857,000.000 USD th in Mar 2018. This records a decrease from the previous number of 9,407,000.000 USD th for Dec 2017. US: ABT: Net Cash/ (Debt), Period End data is updated quarterly, averaging 2,775,249.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 18,620,000.000 USD th in Dec 2016 and a record low of 482,137.000 USD th in Jun 2002. US: ABT: Net Cash/ (Debt), Period End data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 3,857,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Net Cash/ (Debt), Period End from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Net Current Assets
US: ABT: Net Current Assets data was reported at 5,954,000.000 USD th in Mar 2018. This records a decrease from the previous number of 11,235,000.000 USD th for Dec 2017. US: ABT: Net Current Assets data is updated quarterly, averaging 4,328,147.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 20,116,000.000 USD th in Dec 2016 and a record low of -2,697,452.000 USD th in Mar 2001. US: ABT: Net Current Assets data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 5,954,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Net Current Assets from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Net Income
US: ABT: Net Income data was reported at 1,151,000.000 USD th in Jun 2018. This records an increase from the previous number of 418,000.000 USD th for Mar 2018. US: ABT: Net Income data is updated quarterly, averaging 1,714,940.000 USD th from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 5,963,000.000 USD th in Dec 2012 and a record low of -223,613.000 USD th in Mar 2001. US: ABT: Net Income data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 1,151,000.00 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |
View United States's United States US: ABT: Net Income from Dec 1999 to Jun 2018 in the chart:
United States US: ABT: Net Income after Tax
US: ABT: Net Income after Tax data was reported at 1,127,000.000 USD th in Jun 2018. This records an increase from the previous number of 409,000.000 USD th for Mar 2018. US: ABT: Net Income after Tax data is updated quarterly, averaging 1,397,152.000 USD th from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 5,745,838.000 USD th in Dec 2009 and a record low of -223,613.000 USD th in Mar 2001. US: ABT: Net Income after Tax data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 1,127,000.00 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |
View United States's United States US: ABT: Net Income after Tax from Dec 1999 to Jun 2018 in the chart:
United States US: ABT: Net Income before Tax
US: ABT: Net Income before Tax data was reported at 1,208,000.000 USD th in Jun 2018. This records an increase from the previous number of 431,000.000 USD th for Mar 2018. US: ABT: Net Income before Tax data is updated quarterly, averaging 1,883,148.000 USD th from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 7,193,774.000 USD th in Dec 2009 and a record low of -388,684.000 USD th in Mar 2001. US: ABT: Net Income before Tax data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 1,208,000.00 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |
View United States's United States US: ABT: Net Income before Tax from Dec 1999 to Jun 2018 in the chart:
United States US: ABT: Non Current Assets
US: ABT: Non Current Assets data was reported at 55,944,000.000 USD th in Mar 2018. This records a decrease from the previous number of 56,103,000.000 USD th for Dec 2017. US: ABT: Non Current Assets data is updated quarterly, averaging 24,782,806.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 56,103,000.000 USD th in Dec 2017 and a record low of 7,907,013.000 USD th in Dec 2000. US: ABT: Non Current Assets data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 55,944,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Non Current Assets from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Reserves
US: ABT: Reserves data was reported at 23,856,000.000 USD th in Mar 2018. This records a decrease from the previous number of 23,978,000.000 USD th for Dec 2017. US: ABT: Reserves data is updated quarterly, averaging 14,227,268.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 25,884,000.000 USD th in Jun 2016 and a record low of 6,174,007.000 USD th in Dec 1999. US: ABT: Reserves data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 23,856,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Reserves from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Revenue
US: ABT: Revenue data was reported at 15,157,000.000 USD th in Jun 2018. This records an increase from the previous number of 7,390,000.000 USD th for Mar 2018. US: ABT: Revenue data is updated quarterly, averaging 13,177,625.000 USD th from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 35,166,721.000 USD th in Dec 2010 and a record low of 3,353,178.000 USD th in Mar 2000. US: ABT: Revenue data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 15,157,000.00 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |
View United States's United States US: ABT: Revenue from Dec 1999 to Jun 2018 in the chart:
United States US: ABT: Share Capital
US: ABT: Share Capital data was reported at 13,276,000.000 USD th in Mar 2018. This records an increase from the previous number of 12,981,000.000 USD th for Dec 2017. US: ABT: Share Capital data is updated quarterly, averaging 3,562,210.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 13,276,000.000 USD th in Mar 2018 and a record low of 1,681,917.000 USD th in Dec 1999. US: ABT: Share Capital data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 13,276,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Share Capital from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Short Term Borrowings
US: ABT: Short Term Borrowings data was reported at 230,000.000 USD th in Mar 2018. This records an increase from the previous number of 206,000.000 USD th for Dec 2017. US: ABT: Short Term Borrowings data is updated quarterly, averaging 2,593,051.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 5,966,820.000 USD th in Mar 2001 and a record low of 45,004.000 USD th in Mar 2004. US: ABT: Short Term Borrowings data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 230,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Short Term Borrowings from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Short Term Investments
US: ABT: Short Term Investments data was reported at 185,000.000 USD th in Mar 2018. This records a decrease from the previous number of 203,000.000 USD th for Dec 2017. US: ABT: Short Term Investments data is updated quarterly, averaging 842,788.500 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 7,129,000.000 USD th in Jun 2015 and a record low of 48,896.000 USD th in Mar 2002. US: ABT: Short Term Investments data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 185,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Short Term Investments from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Short Term Portion of LT Debt
US: ABT: Short Term Portion of LT Debt data was reported at 507,000.000 USD th in Mar 2018. This records a decrease from the previous number of 508,000.000 USD th for Dec 2017. US: ABT: Short Term Portion of LT Debt data is updated quarterly, averaging 270,879.500 USD th from Dec 2000 (Median) to Mar 2018, with 64 observations. The data reached an all-time high of 2,218,542.000 USD th in Sep 2010 and a record low of 2,379.000 USD th in Dec 2001. US: ABT: Short Term Portion of LT Debt data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 507,000.00 Mar 2018 | quarterly | Dec 2000 - Mar 2018 |
View United States's United States US: ABT: Short Term Portion of LT Debt from Dec 2000 to Mar 2018 in the chart:
United States US: ABT: Tangible Fixed Assets
US: ABT: Tangible Fixed Assets data was reported at 7,659,000.000 USD th in Mar 2018. This records an increase from the previous number of 7,607,000.000 USD th for Dec 2017. US: ABT: Tangible Fixed Assets data is updated quarterly, averaging 6,012,982.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 8,128,450.000 USD th in Jun 2011 and a record low of 4,740,584.000 USD th in Sep 2000. US: ABT: Tangible Fixed Assets data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 7,659,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Tangible Fixed Assets from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Tax
US: ABT: Tax data was reported at 81,000.000 USD th in Jun 2018. This records an increase from the previous number of 22,000.000 USD th for Mar 2018. US: ABT: Tax data is updated quarterly, averaging 350,000.000 USD th from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 1,878,000.000 USD th in Dec 2017 and a record low of -274,000.000 USD th in Dec 2012. US: ABT: Tax data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 81,000.00 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |
View United States's United States US: ABT: Tax from Dec 1999 to Jun 2018 in the chart:
United States US: ABT: Total Assets
US: ABT: Total Assets data was reported at 70,908,000.000 USD th in Mar 2018. This records a decrease from the previous number of 76,250,000.000 USD th for Dec 2017. US: ABT: Total Assets data is updated quarterly, averaging 41,192,286.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 76,250,000.000 USD th in Dec 2017 and a record low of 14,471,044.000 USD th in Dec 1999. US: ABT: Total Assets data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 70,908,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Total Assets from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Total Liabilities
US: ABT: Total Liabilities data was reported at 39,307,000.000 USD th in Mar 2018. This records a decrease from the previous number of 45,152,000.000 USD th for Dec 2017. US: ABT: Total Liabilities data is updated quarterly, averaging 19,962,169.000 USD th from Dec 1999 (Median) to Mar 2018, with 74 observations. The data reached an all-time high of 45,152,000.000 USD th in Dec 2017 and a record low of 6,666,500.000 USD th in Sep 2000. US: ABT: Total Liabilities data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 39,307,000.00 Mar 2018 | quarterly | Dec 1999 - Mar 2018 |
View United States's United States US: ABT: Total Liabilities from Dec 1999 to Mar 2018 in the chart:
United States US: ABT: Weighted Ordinary Share Issued
US: ABT: Weighted Ordinary Share Issued data was reported at 1,767,000,000.000 Unit in Jun 2018. This records an increase from the previous number of 1,753,412,000.000 Unit for Mar 2018. US: ABT: Weighted Ordinary Share Issued data is updated quarterly, averaging 1,548,554,000.000 Unit from Dec 1999 (Median) to Jun 2018, with 75 observations. The data reached an all-time high of 1,767,000,000.000 Unit in Jun 2018 and a record low of 1,476,161,000.000 Unit in Jun 2016. US: ABT: Weighted Ordinary Share Issued data remains active status in CEIC and is reported by Abbott Laboratories. The data is categorized under World Trend Plus’s Top Company: Pharmaceutical and Biotechnology: Non-Asia – Table RT.NA001: Abbott Laboratories (ABT): Financial Highlights.
| Last | Frequency | Range |
|---|---|---|
| 1,767,000,000.00 Jun 2018 | quarterly | Dec 1999 - Jun 2018 |